These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4191095)

  • 1. [Regression of experimental silicotic granuloma under the influence of polyvinylpyridin-N-oxide].
    Grundmann E; Schlipköter HW
    Verh Dtsch Ges Pathol; 1969; 53():367-70. PubMed ID: 4191095
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of experimental silicosis with polyvinyl-pyridine-N-oxide].
    Bogdanskaia NI
    Gig Tr Prof Zabol; 1973 May; 17(5):22-5. PubMed ID: 4771393
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prophylactic action of polyvinylpyridine-N-oxide of different molecular weights on experimental silicosis].
    Bogdanskaia NI; Tolgskaia MS
    Gig Sanit; 1973 Apr; 38(4):102-4. PubMed ID: 4731236
    [No Abstract]   [Full Text] [Related]  

  • 4. ["Studies of the effect of polyvinylpyridine-N-oxide (P 204) on the metabolism of the connective tissue". II].
    Junge-Hülsing G; Wagner H; Einbrodt HJ
    Beitr Silikoseforsch; 1968; 94():41-57. PubMed ID: 4239045
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antifibrous action of polyvinyl-pyridine-N-oxides in experimental silicosis].
    Bezrodnykh AA; Kasparov AA; Mazurov VI; Razvodovskiĭ EF; Kochetkova TA
    Gig Tr Prof Zabol; 1973 Dec; 17(12):20-4. PubMed ID: 4789533
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antisilicotic properties of polyvinylpyridine-N-oxide with a different molecular weight].
    Dubovik BV; Shadurskiĭ KS; Etlis VS; Lushnikova GA; Shevchuk AS
    Farmakol Toksikol; 1971; 34(3):352-7. PubMed ID: 5568700
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hydroxyproline content in the peptide makeup of the lung tissue of animals with experimental silicosis].
    Rodkina BS
    Ukr Biokhim Zh; 1974; 46(3):393-7. PubMed ID: 4836947
    [No Abstract]   [Full Text] [Related]  

  • 8. [Animal experimental fundamentals in the medicinal prevention of silicosis using polyvinylpyridine-N-oxide (P204)].
    Pott F; Schlipköter HW; Brockhaus A
    Dtsch Med Wochenschr; 1968 Dec; 93(51):2479-82. PubMed ID: 5724499
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of the human liver during silicosis therapy using polyvinylpyridine-N-oxide (PVNO)].
    Haas P; Huber W
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):91-100. PubMed ID: 5171411
    [No Abstract]   [Full Text] [Related]  

  • 10. [Detoxicating effects of poly-2-vinylpyridine-N-oxide].
    Antweiler H
    Beitr Silikoseforsch Pneumokoniose; 1970; 22(3):93-172. PubMed ID: 4325737
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of polyvinylpyridine-N-oxide on matured experimental silicosis in the liver-spleen test].
    Heeren E; Eger W; Einbrodt HJ
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):137-50. PubMed ID: 5171409
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of polyvinylpyridine N-oxide on pulmonary tissue scleroproteins in experimental silicosis].
    Gel'fon IA
    Gig Tr Prof Zabol; 1978 Sep; (9):54. PubMed ID: 689462
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental silicosis caused by the dust from extra-pure crystalline silicon and the effect of polyvinylpyridine N-oxide on its course].
    Golodnikov IuN
    Gig Tr Prof Zabol; 1978 Dec; (12):31-6. PubMed ID: 720881
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of polyvinylpyridine N-oxide for treating experimental silicosis and anthracosilicosis].
    Deĭnega VG; Bolonova LN; Sukhanov VV; Zemliakova LF; Tkachuk SV
    Gig Tr Prof Zabol; 1977; (6):25-8. PubMed ID: 892540
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possible paths for influencing the mechanism of experimental silicosis].
    Shnaĭdman IM; Raĭkhlin NT
    Biull Eksp Biol Med; 1973 Jun; 75(6):27-30. PubMed ID: 4149770
    [No Abstract]   [Full Text] [Related]  

  • 16. [CC1-4 detoxication by poly-2-vinylpyridine-N-oxide in rats].
    Antweiler H; Dehnen W
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):290-1. PubMed ID: 4253735
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advances in the study of anti-silicotic agents].
    Huang FZ; Li QL; Qu SJ
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Apr; 9(2):118-21. PubMed ID: 3527609
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical studies on the elimination of hydroxyproline during treatment of silicosis in man with polyvinyl-pyridine-N-oxide (author's transl)].
    Schlipköter H; Grünspan M; Dehnen W; Mallner B
    Infection; 1974; 2(1):25-8. PubMed ID: 4598261
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preventive and curative silicotropic effect of polyvinylpyridine-N-oxide in liver and spleen tests].
    Hennies H; Eger K; Eger W
    Beitr Silikoseforsch; 1967; 93():15-32. PubMed ID: 6072453
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of serum polyvinylpyridine-N-oxide after intravenous administration in silicosis patients].
    Grünspan M; Antweiler H; Marcic I
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):101-13. PubMed ID: 5171408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.